Contributor
Sophie Schmitz
Menu
Sophie Schmitz
The team discuss the NORD summit particularly FDA commissioner Scott Gottleib’s presentation; a panel discussion on cell and gene therapy pricing as well as P4A’s lunch and learn on cell and gene therapy access – learnings from the EU.
Also in this episode, Novartis’ Kymriah innovative payment agreement in Italy, the changing evaluation trends for gene therapies among HTA bodies and Alliance for Regenerative Medicines’ Q3 report.
Presenter: Jack Rawson
Contributor: Sophie Schmitz
Producer: Aparna Krishnan
